Management of Total Parenteral Nutrition (TPN)

Patient Selection and Indications

• TPN is indicated for patients who cannot be adequately nourished through oral or enteral routes and require nutritional support for at least 3 months 1
• Patients must be metabolically stable before initiating home TPN (HPN) 2, 3
• The patient's home environment must be assessed for adequacy to safely deliver TPN therapy 2, 3
• Patients and/or caregivers must be able to understand and perform the procedures required for safe TPN administration 2, 3

Vascular Access

• Tunneled central catheters are recommended for long-term TPN administration 4, 2
• Implanted ports are an acceptable alternative for selected patients 4
• PICC lines are intended for shorter-term use and are not recommended for long-term HPN 4
• Single-lumen catheters are preferred over multi-lumen catheters to minimize infection risk 4
• The catheter tip should be positioned at the superior vena cava-right atrium junction 5
• The exit site should be easily visualized and accessible for self-caring patients 2

Nutritional Requirements

Energy Requirements

• Total energy provision should be 100-150 kcal per gram of nitrogen 4
• For long-term HPN, 70-85% of non-protein calories should come from glucose and 15-30% from lipids 4
• For patients with liver disease, glucose should cover 50-60% of non-protein energy requirements and lipids 40-50% 6

Protein Requirements

• Standard protein provision for stable adults: 0.8-1.0 g/kg/day 4
• For stressed or catabolic patients: up to 2.0 g/kg/day 4
• For obese patients (BMI 30-40 kg/m²): use approximately 75% of the value estimated from body weight 4
• For severely obese patients (BMI >50 kg/m²): use approximately 65% of the value estimated from body weight 4

Lipid Requirements

• Lipid emulsions with lower content of n-6 unsaturated fatty acids are preferred over traditional pure soybean oil emulsions 6
• Limit lipid provision to no more than 1 g/kg/day of 20% n-6 rich lipid emulsion to prevent intrahepatic cholestasis 5

Micronutrients

• TPN should include all 35 essential nutrients (electrolytes, minerals, vitamins, and trace elements) 5
• Micronutrient requirements should be tailored according to the clinical and intestinal status of individual patients 5
• Trace elements should be administered daily in standard TPN doses 6
• For zinc, routine administration of twice the normal daily requirement (25 mg/day) is recommended 6

Administration Protocol

• Initially, TPN may be infused continuously while postoperative complications are addressed and metabolic issues stabilized 1
• For home TPN, infusion should be compressed to overnight hours (typically 10 hours with an additional 30-60 minute taper period) 1
• Cycling to overnight infusion should be a gradual process, compressing by increments of 2-4 hours 1
• If possible, parenteral requirements should be provided over five/six nights rather than seven to improve quality of life 4

Monitoring and Management

• Blood glucose should be monitored at least daily, optimally four times daily, and maintained at 180-200 mg/dL 1
• If insulin is required, it should be added to the TPN bag at an initial dose of 0.1 U/g dextrose 1
• Serum triglyceride concentration should be kept below 400-800 mg/dL 1

Special Considerations

Liver Disease

• In cirrhotic patients who must fast temporarily for more than 12 hours, provide IV glucose at 2-3 g/kg/day 6
• When fasting exceeds 72 hours in cirrhotic patients, total PN is required 6

Transfer Between Facilities

• TPN can be safely discontinued for short transfers (<2 hours) 7
• For longer transfers, coordination between sending and receiving facilities is essential 7
• The receiving facility should be prepared to resume TPN promptly upon patient arrival 7
• For patients at risk of hypoglycemia, consider a maintenance dextrose infusion during transfer 7

Complications Prevention

• Catheter-related bloodstream infections can be minimized through proper catheter care and aseptic technique 2, 8
• Metabolic complications can be reduced by avoiding exclusive intravenous feeding and implementing enteral feeding when possible 9

Training and Education

• A formal individualized HPN training program should be provided for the patient and/or caregiver 8
• Training should include catheter care, pump use, and preventing, recognizing, and managing complications 8
• Written policies and procedures should be provided to complement oral instructions 8
• Patients should be taught proper storage and handling of TPN solutions and supplies 8

TPN Pause Duration Before Laboratory Testing

Key Considerations for Laboratory Monitoring

• In clinically stable patients on long-term TPN, biochemistry testing should be measured every three to six months without requiring TPN interruption, as recommended by Clinical Nutrition guidelines 10, 11.
• Laboratory monitoring frequency should be more intensive during the early months of TPN or when there are changes in the patient's clinical condition, according to Clinical Nutrition guidelines 11.
• For patients on long-term home TPN, vitamin and trace metal analyses should be performed 2-3 times yearly, and whenever possible deficiencies are clinically recognized, as suggested by Gastroenterology guidelines 12.

Practical Approach

• Draw routine laboratory tests without pausing TPN in stable patients, as recommended by Clinical Nutrition guidelines 10, 11.
• Schedule laboratory draws during regular monitoring intervals regardless of TPN infusion status, according to Clinical Nutrition guidelines 10, 11.
• For patients on cyclic TPN, drawing labs during the off-cycle period provides baseline values without TPN influence, as suggested by Clinical Nutrition guidelines 13.

Common Pitfalls to Avoid

• Do not unnecessarily interrupt TPN for routine laboratory monitoring, as this provides no established benefit and may disrupt the patient's nutritional support schedule, as recommended by Clinical Nutrition guidelines 10, 11.
• For triglyceride monitoring, the timing relative to lipid infusion may be relevant, though specific guidelines for pausing TPN before lipid panel testing are not established in the available evidence, according to Clinical Nutrition guidelines 14.